Research Article

Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease

Table 3

Diagnostic performances of TE in patients with different degrees of hepatic steatosis for liver fibrosis and cirrhosis assessment.

Statistic5% ≤HS<10% (n=33)10%≤HS<20% (n=26)HS ≥20% (n=35)

Significant fibrosis assessment (F≥2)
AUC0.78 (0.60, 0.90)0.79 (0.59, 0.93)0.93 (0.79, 0.99)
Standard error0.0830.0920.041
Cut-off value6.66.88.4
Sensitivity (%)83.3 (58.6, 96.4)66.7 (34.9, 90.1)76.5 (50.1, 93.2)
Specificity (%)66.7 (38.4, 88.2)85.7 (57.2, 98.2)100.0 (81.5, 100.0)
PPV (%)75.0 (50.9, 91.3)80.0 (44.4, 97.5)100.0 (75.3, 100.0)
NPV (%)76.9 (46.2, 95.0)75.0 (47.6, 92.7)81.8 (59.7, 94.8)
Comparison of AUCs
5% ≤HS<10%-P=0.94P=0.11
10%≤HS<20%P=0.94-P=0.16
HS ≥20%P=0.11P=0.16-
Advanced fibrosis assessment (F≥3)
AUC0.96 (0.83, 0.99)0.94 (0.77, 0.99)0.95 (0.82, 0.99)
Standard error0.0370.0540.039
Cut-off value8.67.28.4
Sensitivity (%)90.0 (55.5, 99.7)85.7 (42.1, 99.6)85.7 (57.2, 98.2)
Specificity (%)95.7 (78.1, 99.9)89.5 (66.9, 98.7)95.2 (76.2, 99.9)
PPV (%)90.0 (55.5, 99.7)75.0 (34.9, 96.8)92.3 (64.0, 99.8)
NPV (%)95.7 (78.1, 99.9)94.4 (72.7, 99.9)90.9 (70.8, 98.9)
Comparison of AUCs
5% ≤HS<10%-P=0.76P=0.85
10%≤HS<20%P=0.76-P=0.88
HS ≥20%P=0.85P=0.88-
Cirrhosis assessment (F=4)
AUC1.00 (0.89, 1.00)0.98 (0.79, 1.00)0.90 (0.75, 0.98)
Standard error0.0000.0290.076
Cut-off value10.710.010.9
Sensitivity (%)100.0 (59.0, 100.0)100.0 (15.8, 100.0)80.0 (28.4, 99.5)
Specificity (%)100.0 (86.8, 100.0)95.8 (78.9, 99.9)86.7 (69.3, 96.2)
PPV (%)100.0 (59.0, 100.0)66.7 (9.4, 99.2)50.0 (15.7, 84.3)
NPV (%)100.0 (86.8, 100.0)100.0 (85.2, 100.0)96.3 (81.0, 99.9)
Comparison of AUCs
5% ≤HS<10%-P=0.49P=0.19
10%≤HS<20%P=0.49-P=0.33
HS ≥20%P=0.19P=0.33-

Data in parentheses were 95% confidence interval. AUC=area under the ROC curve. HS=hepatic steatosis. PPV=positive predictive value. NPV=negative predictive value.